pLVTH-sip53 Citations (8)

Originally described in: Conditional suppression of cellular genes: lentivirus vector-mediated drug-inducible RNA interference.
Wiznerowicz M, Trono D J Virol. 2003 Aug . 77(16):8957-61. PubMed Journal

---

Articles Citing pLVTH-sip53

Articles
miR-125b Is an adhesion-regulated microRNA that protects mesenchymal stem cells from anoikis. Yu X, Cohen DM, Chen CS. Stem Cells. 2012 May;30(5):956-64. doi: 10.1002/stem.1064. PubMed
Metabolic correction of congenital erythropoietic porphyria with iPSCs free of reprogramming factors. Bedel A, Taillepierre M, Guyonnet-Duperat V, Lippert E, Dubus P, Dabernat S, Mautuit T, Cardinaud B, Pain C, Rousseau B, Lalanne M, Ged C, Duchartre Y, Richard E, de Verneuil H, Moreau-Gaudry F. Am J Hum Genet. 2012 Jul 13;91(1):109-21. doi: 10.1016/j.ajhg.2012.05.026. PubMed
Humanization of the mouse mammary gland by replacement of the luminal layer with genetically engineered preneoplastic human cells. Verbeke S, Richard E, Monceau E, Schmidt X, Rousseau B, Velasco V, Bernard D, Bonnefoi H, MacGrogan G, Iggo RD. Breast Cancer Res. 2014 Dec 20;16(6):504. doi: 10.1186/s13058-014-0504-9. PubMed
Regulation of protein quality control by UBE4B and LSD1 through p53-mediated transcription. Periz G, Lu J, Zhang T, Kankel MW, Jablonski AM, Kalb R, McCampbell A, Wang J. PLoS Biol. 2015 Apr 2;13(4):e1002114. doi: 10.1371/journal.pbio.1002114. eCollection 2015 Apr. PubMed
eEF2K inhibition blocks Abeta42 neurotoxicity by promoting an NRF2 antioxidant response. Jan A, Jansonius B, Delaidelli A, Somasekharan SP, Bhanshali F, Vandal M, Negri GL, Moerman D, MacKenzie I, Calon F, Hayden MR, Taubert S, Sorensen PH. Acta Neuropathol. 2017 Jan;133(1):101-119. doi: 10.1007/s00401-016-1634-1. Epub 2016 Oct 17. PubMed
Mad2 Overexpression Uncovers a Critical Role for TRIP13 in Mitotic Exit. Marks DH, Thomas R, Chin Y, Shah R, Khoo C, Benezra R. Cell Rep. 2017 May 30;19(9):1832-1845. doi: 10.1016/j.celrep.2017.05.021. PubMed
The role of PTEN - HCV core interaction in hepatitis C virus replication. Wu Q, Li Z, Mellor P, Zhou Y, Anderson DH, Liu Q. Sci Rep. 2017 Jun 16;7(1):3695. doi: 10.1038/s41598-017-03052-w. PubMed
MDM2 Antagonists Induce a Paradoxical Activation of Erk1/2 through a P53-Dependent Mechanism in Dedifferentiated Liposarcomas: Implications for Combinatorial Strategies. Roy S, Laroche-Clary A, Verbeke S, Derieppe MA, Italiano A. Cancers (Basel). 2020 Aug 12;12(8). pii: cancers12082253. doi: 10.3390/cancers12082253. PubMed

If you have published an article using this material, please email us at to have your article added to this page.